histology study on piriton treatment for 10 day
TRANSCRIPT
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
1/48
(12) Group member names:
Wong Li Hun D20091034877Wang Chiao Ching D20091034838
Ngang Huey Chi D20091034861
Yee Chin Tien D20091034824
Lee Yian Ping D20091034823
Chew Mei Ping D20091034816
Mazatul azrin bin Rahman D20091034846Muhammad hafiz bin Kadir D20091034812
Yee Hon Kit D20091034822
Rio Raydy Anak Ujang D20091034835
Mariani bt Zakaria D20091034650
Ameera bt Yahya D20091034814
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
2/48
INTRODUCTIONWe begin the experiment with different patter colour
of mice which make us easier to identify it during theprocess of weighting. We used the treatment of 500mg
piriton drugs for ten day in ad libitum. The mice were putsin a cage and places outside the corridor of the lab for tensday. we schedule the time to feed the mice. Also record themice weight changes and amount of piriton consumed eachday. After tens day we dissect the mice and we extract the
organ that we needed and those organ are inserted inethanol 70% for weeks. We choose mice because its easierto obtain and easily handled so that we can conserveresources that we use such as the dosage of piriton due thesmall size of mice.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
3/48
PROBLEM STATEMENT
We find it is difficult to make sure that the mice wereconsumed same amount of piriton during the
experiment. not all the organs that we extact is used inthe making of slides. The present of air bubbles withinthe organ make us difficult in the process of sliding.
The origin of mice/body condition of mice before
inducement of piriton.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
4/48
PURPOSE OF STUDY
y To study the effects of piriton in schedule time towardsthe organ of animals such as mice, to prepare animals
tissue slide for comparison in terms of histology withnormal animal slide which include heart, lung, kidneyoesophagus, intestine, liver, ovary and uterus.Purpsose of study also is to enchance the knowledgeabout the piriton drugs which widely used intreatments.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
5/48
SIGNIFICANCE OF PROJECT
This project will be the prove that over usage of thisdrugs will lead to harmfulness of our healthy. It is also
to make sure, that the drugs is safely used by control ofthe dosage of drugs. As piriton is a widely usedantihistaminic drug in human and veterinarymedicine.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
6/48
RESEARCH LIMITATIONSy Our project will significant only in the mice that we
used. The result may be different in different species or
animals due to the reactions toward piriton may varyusing different method.
y Time is also another factor as the period ofinducement of piriton is limited.
yMoreover ,there is problem with equipment.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
7/48
BRIEF LITERATURE REVIEW
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
8/48
Mice are divided into several group. 1 group
as the vehicle control. The other group aretreatened with higher dose of piriton.
The group that treatened with piriton have a
much lower survival rate in compare to thevehicle group.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
9/48
y There are several effect that occur to the thyroid gland ofthe mice.
They are thyroid gland follicular cyst,
Thyroid gland follicular cell hyperplasia ,
thyroid gland follicular cell adenoma.
y A subcutaneous tissue tumors were found in male mice.
y . Chlorpheniramine maleate had a proliferative effect in
the thyroid gland of female mice, as shown by theincreased incidences of follicular cell cysts andhyperplasia in both low dose and high dose groups.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
10/48
y The major route of excretion of chlorpheniramine or its
metabolites is in the urine. In male rats orallyadministered 14C-chlorpheniramine maleate at doses of 2or 20 mg/kg, there was essentially no difference in thepercentage of urinary or fecal excretion of radioactivitybetween these dose levels.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
11/48
Effect of piriton on the mobility of T lymphocyte
y T lymphocyte mobility is low in subject with lowneutrophil mobility.
y Histamine accelerates mobility of T lymphocytes in
healthy subject and subject with diseases.y Piriton is an antihistamine drug which preventing the
histamine to bind to specific receptor on the cell.
y Without the histamine binding to the cell, the mobility
of T lymphocyte through the membrane of the cell isgreatly reduced
y This can bring a much worse effect toward the health ofthe mice
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
12/48
Material & Methods
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
13/48
MATERIAL:y Organ(liver, lungs, kidney, hearts, ovaries/testes,intestine) of 5 mices,
piritonsolution, normal saline solution, Bouinss solution, ethanolsolution (70%,80%,95%,100%), toluene solution, paraffin solution,
Xilen, pure alcohol, alcohol( 75%,80%,90%), distilled water,hematoksilin solution, 0.5% hydrochloric acid solution, 0.5%sodiumbicarbonate solution, scotts solution, Eosin, microtom and CanadaBalsam.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
14/48
Methods:
Fixation.
Dehydration
ClearingEmbeding
Dissecting
Staining
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
15/48
RESULTS
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
16/48
Cords of
hepatocytes
Portal Vein
Liver sinusoids
Normal Liver (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
17/48
Protal Vein
Branch of Bile Duct
Protal Traid
Branch of Hepatic Arteri
Connective tissue
septum
Normal Liver (400X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
18/48
Central vein
Sinusoids
Cords of
hepatocytes
Affected Liver (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
19/48
Phagocytic
Kupffer Cell
Central Vein
Sinusoids
Affected Liver (400X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
20/48
Sinusoid
Phagocytic
Kupffer Cell
Affected Liver (400X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
21/48
Sinusoids
Cords ofhepatocytes
Affected Liver (50X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
22/48
Mucosa
Villus
Intestinal glands
Submucosa
Circular layer
Longitudinal layer
Serosa
Normal Small Intestine (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
23/48
Serosa
Intestinal gland
Muscularis
externa
Small Intestine l.s. (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
24/48
Brunnergland
Serosa
Submucosa
Lumen
Intestinalgland
Microvilli
Small Intestine l.s. (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
25/48
Intestinal glands
Muscularis externa
Lumen
Mucosa
Submucosa
Serosa
Large Intestine c.s (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
26/48
Capsular space
Distal convoluted tubule
Renal corpuscle
Proximal convoluted tubules
Normal Kidney (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
27/48
Kidney (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
28/48
Renal orpuscle
Proximal convoluted tubules
Renal orpuscle
Proximal convoluted tubules
Mice Kidney (400X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
29/48
Mice Kidney (400X)
Glomerulus
Arterioles
Proximalconvoluted
tubule
Space within
Bowmans
capsule
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
30/48
Aveolar sac
SmoothMuscle
Lumen
Pseudostratifiedcolumnar epithelium
Bronchus
Vein
Artery
Normal Human Lung (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
31/48
Bronchiole
Vein
Pseudostratified columnar
epithelium
Lumen
Mucosa
Lung (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
32/48
Lung (100X)
Vein
Lumen
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
33/48
Epicardium
Myocardium
Capillaries
Normal Heart (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
34/48
Myocardium
Epicardium
Blood in
Lumen
Endocardium
Myocardium
Heart (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
35/48
NormalMice Ovary (100X)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
36/48
Ovarian Vein
Secondary follicles
Primary oocyte
Mature secondaryoocyte
Corpus albicans
Ovary (40X)
Corpus luteum
This section through an ovary shows follicles in various stages ofdevelopment.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
37/48
Ovary (100X)
GerminalEpithelium
(surface)
Tunica
albuginea
Secondary
follicle
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
38/48
Mice Ovary (100X)
Secondary follicle
Tunica albuginea
Vein
Modullarly region
Corpus luteum
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
39/48
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
40/48
PIRITONy contain active ingredient chlorpheniramine maleate.
y effective antihistamine for all allergic conditions
y If overdose will cause side effect such as hepatitis,urinary retention, arrhythmia and drowsiness.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
41/48
THE EFFECT OF AFFECTED LIVERThese organs are implicated after the liver is
affected.
Heart
Kidney
The uterus & ovaries
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
42/48
SUGGESTIONy Based on the research done by U.S. Department Of
Health And Human Services, Public Health
Service National Institutes of Health namedToxicology and Carcinogenesis Studies OfChlorpheniramine Maleate (CAS NO.113-92-8) INf344/N Rats and B6C3F1 Mice, they stated no
microscopic pathologic effects were observed inmice in 16 days or 13 weeks studies.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
43/48
y It is suggested to increase the period of studies up totwo years.
y This is because no hyperactivity and hyperexcitabilityshown in 13 weeks studies
y
Besides, no significant positive trends or increases inthe incidences of neoplasms in either male or femalemice dosed with chlorpheniramine maleate for 103
weeks.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
44/48
The line chart showing the relationship of the
weight of mice and period of studies
0
10
20
30
40
50
60
70
80
90
100
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10
Weight (g)
Weight (g)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
45/48
y Based on the line chart above, the average weight of the
mice are increasing with accordance to period ofstudies, that is from day 1 till day 10.y From the chart, we can concluded that piriton didnt have
any effect on the appetite of the mice.y The mice gained weight continueously since the start of
experiment.y Other than that, there are other factors that may
contributes to this result.y The mice lack of exercise since they are kept in a cage.y They dont have much space to move around compare to
their original habitat.y The mice no need to compete for food since there are
abundant supply.y They no need to go around and hunt for food.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
46/48
The line chart showing the relationship of dosage(mg/g)
use in mice against the period of study.
0
2
4
6
8
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day
Day 10
Dosage (mg/g)
Dosage (mg/g)
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
47/48
y The dosage of piriton in the body of mice decreaseswith period of study.
y This is because the mice are gaining weight each daybut the amount of piriton used in the experimentremain the same, that is 500mg each day.
yWhen we divide the amount of piriton given with theweight of mice, we can see that the distribution ofpiriton less in each gram of the mice.
-
8/8/2019 Histology Study on Piriton Treatment for 10 Day
48/48
THE END